Page last updated: 2024-10-21
1,3-dipropyl-8-cyclopentylxanthine and Insulinoma
1,3-dipropyl-8-cyclopentylxanthine has been researched along with Insulinoma in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Verspohl, EJ | 1 |
| Johannwille, B | 1 |
| Waheed, A | 1 |
| Neye, H | 1 |
Other Studies
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Insulinoma
| Article | Year |
|---|---|
Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.
Topics: Adenosine Deaminase; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cell Line; Estrenes; Fe | 2002 |